Guardant Health Fda Panel

Listing Websites about Guardant Health Fda Panel

Filter Type:

Guardant Health, Inc. - FDA Advisory Panel Review of Guardant …

(1 days ago) WEBGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical Genetics Panel of the U.S. Food and Drug Administration Medical Devices Advisory Committee is scheduled to review the premarket approval (PMA) application for the company’s Shield™ blood test for …

https://investors.guardanthealth.com/press-releases/press-releases/2024/FDA-Advisory-Panel-Review-of-Guardant-Healths-Shield-Blood-Test-to-Screen-for-Colorectal-Cancer-to-Be-Held-on-May-23/default.aspx

Category:  Food,  Medical Show Health

Guardant preps for FDA review of colorectal cancer blood test

(9 days ago) WEBGuardant Health preps for FDA advisory panel review of its blood-based colorectal cancer screening test. Technically, Shield has been available to the public since mid-2022, reaching the market as

https://www.fiercebiotech.com/medtech/guardant-health-preps-fda-advisory-panel-review-its-blood-based-colorectal-cancer-screening

Category:  Cancer Show Health

FDA Advisory Panel Review of Guardant Health’s Shield™ Blood …

(Just Now) WEBPALO ALTO, Calif., April 22, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical Genetics Panel of the U.S. Food and Drug

https://finance.yahoo.com/news/fda-advisory-panel-review-guardant-125200837.html

Category:  Food Show Health

Federal Register :: Molecular and Clinical Genetics Panel of the

(3 days ago) WEBAnswers to commonly asked questions about FDA advisory committee meetings, including information regarding special accommodations due to a disability may be accessed at: The test is performed at Guardant Health, Inc. FDA intends to make background material available to the public no later than 2 business days before the …

https://www.federalregister.gov/documents/2024/04/23/2024-08656/molecular-and-clinical-genetics-panel-of-the-medical-devices-advisory-committee-notice-of

Category:  Health Show Health

Guardant Health to present real-world data supporting …

(5 days ago) WEBAn FDA Advisory Panel is scheduled to review the PMA application on May 23. The full abstracts for Guardant Health and a list of all abstracts being presented at the meeting will be available at

https://www.businesswire.com/news/home/20240516838593/en/Guardant-Health-to-present-real-world-data-supporting-performance-of-Shield%E2%84%A2-blood-test-for-colorectal-cancer-screening-at-2024-Digestive-Disease-Week

Category:  Health Show Health

FDA Advisory Panel Review of Guardant Health’s Shield

(8 days ago) WEBFDA Advisory Panel Review of Guardant Health’s Shield™ Blood Test to Screen for Colorectal Cancer to Be Held on May 23 Provided by Business Wire. Apr 22, 2024 12:52pm About Guardant Health.

https://www.morningstar.com/news/business-wire/20240421042636/fda-advisory-panel-review-of-guardant-healths-shield-blood-test-to-screen-for-colorectal-cancer-to-be-held-on-may-23

Category:  Cancer Show Health

Guardant Health Announces Tentative Date of FDA Advisory Panel …

(6 days ago) WEBPALO ALTO, Calif., December 19, 2023--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration’s Molecular and

https://finance.yahoo.com/news/guardant-health-announces-tentative-date-210500885.html

Category:  Food Show Health

Guardant Health Announces Tentative Date of FDA Advisory Panel …

(8 days ago) WEBGuardant Health, Inc., a leading precision oncology company, today announced that the U.S. Food and Drug Administration’ s Molecular and Clinical Genetics Panel of the Medical Devices Advisory

https://www.nasdaq.com/press-release/guardant-health-announces-tentative-date-of-fda-advisory-panel-review-of-shieldtm

Category:  Food,  Medical Show Health

FDA Advisory Panel Review of Guardant Health’s Shield - BioSpace

(Just Now) WEBPALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical Genetics Panel of the U.S. Food and Drug Administration Medical Devices Advisory Committee is scheduled to review the premarket approval (PMA) application for the …

https://www.biospace.com/article/releases/fda-advisory-panel-review-of-guardant-health-s-shield-blood-test-to-screen-for-colorectal-cancer-to-be-held-on-may-23/

Category:  Food,  Medical Show Health

FDA Advisory Panel to Review Guardant's Shield Blood Test

(3 days ago) WEBGuardant Health, a precision oncology company, announced that the US Food and Drug Administration’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee is tentatively scheduled to review the premarket approval application (PMA) for the company’s Shield blood test to screen for colorectal cancer on …

https://clpmag.com/disease-states/cancer/colorectal/guardant-gives-tentative-date-of-fda-advisory-panel-review-for-shield-blood-test/

Category:  Food,  Cancer,  Medical Show Health

Guardant Health to present real-world data supporting - BioSpace

(2 days ago) WEBAn FDA Advisory Panel is scheduled to review the PMA application on May 23. The full abstracts for Guardant Health and a list of all abstracts being presented at the meeting will be available at the DDW website. For information and updates from the meeting, follow Guardant Health on LinkedIn, X (Twitter) and Facebook. About …

https://www.biospace.com/article/releases/guardant-health-to-present-real-world-data-supporting-performance-of-shield-blood-test-for-colorectal-cancer-screening-at-2024-digestive-disease-week/

Category:  Health Show Health

FDA Advisory Panel Review of Guardant Health’s Shield™ Blood …

(2 days ago) WEBPALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical Genetics Panel of the U.S. Food and Drug

https://www.streetinsider.com/Business+Wire/FDA+Advisory+Panel+Review+of+Guardant+Health%E2%80%99s+Shield%E2%84%A2+Blood+Test+to+Screen+for+Colorectal+Cancer+to+Be+Held+on+May+23/23094449.html

Category:  Food Show Health

2024-05-16 NDAQ:GH Press Release Guardant Health Inc

(2 days ago) WEBAn FDA Advisory Panel is scheduled to review the PMA application on May 23. The full abstracts for Guardant Health and a list of all abstracts being presented at the meeting will be available at the DDW website. For information and updates from the meeting, follow Guardant Health on LinkedIn, X (Twitter) and Facebook. About …

https://stockhouse.com/news/press-releases/2024/05/16/guardant-health-to-present-real-world-data-supporting-performance-of-shield-tm

Category:  Health Show Health

2023-12-19 NDAQ:GH Press Release Guardant Health Inc

(3 days ago) WEBGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that the U.S. Food and Drug Administration’s Molecular and Clinical Genetics Panel of the Medical Devices Advisory Committee is tentatively scheduled to review the premarket approval …

https://stockhouse.com/news/press-releases/2023/12/19/guardant-health-announces-tentative-date-of-fda-advisory-panel-review-of-shield

Category:  Food,  Medical Show Health

FDA Advisory Panel Review of Guardant Health’s Shield™ Blood …

(2 days ago) WEBGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical Genetics Panel of the U.S. Food and Drug Administration Medical Devices Advisory Committee is scheduled to review the premarket approval (PMA) application for the company’s Shield™ blood test for …

https://www.marketscreener.com/quote/stock/GUARDANT-HEALTH-INC-46434671/news/FDA-Advisory-Panel-Review-of-Guardant-Health-s-Shield-Blood-Test-to-Screen-for-Colorectal-Cance-46491903/

Category:  Food,  Medical Show Health

Guardant Health to present real-world data supporting

(1 days ago) WEBAn FDA Advisory Panel is scheduled to review the PMA application on May 23. The full abstracts for Guardant Health and a list of all abstracts being presented at the meeting will be available at

https://www.morningstar.com/news/business-wire/20240516838593/guardant-health-to-present-real-world-data-supporting-performance-of-shield-blood-test-for-colorectal-cancer-screening-at-2024-digestive-disease-week

Category:  Health Show Health

May 23, 2024: Molecular and Clinical Genetics Panel meeting

(Just Now) WEBOn May 23, 2024, the committee will discuss, make recommendations, and vote on information regarding the premarket approval application for the Shield test by Guardant Health, Inc.

https://www.fda.gov/advisory-committees/advisory-committee-calendar/may-23-2024-molecular-and-clinical-genetics-panel-medical-devices-advisory-committee-meeting

Category:  Health Show Health

FDA Approves First Liquid Biopsy Next-Generation Sequencing …

(7 days ago) WEBThe FDA granted approval for the Guardant360 CDx test to Guardant Health. The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the

https://www.fda.gov/news-events/press-announcements/fda-approves-first-liquid-biopsy-next-generation-sequencing-companion-diagnostic-test

Category:  Health Show Health

Premarket Approval (PMA) - Food and Drug Administration

(9 days ago) WEBNext generation sequencing oncology panel, somatic or germline variant detection system Guardant Health, Inc. 505 Penobscot Drive Redwood City, CA 94063: PMA Number: P200010: Supplement Number: S010: Date Received: 06/21/2022: Decision Date: U.S. Food and Drug Administration. 10903 New Hampshire Avenue Silver …

https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm?id=P200010S010

Category:  Food Show Health

Guardant360® CDx: Fastest FDA-Approved Liquid CGP Panel

(8 days ago) WEBGuardant360® CDx is the fastest FDA-approved CGP panel for all advanced solid tumors including lung, breast, and colorectal cancers. Results in less than 7 days Why Guardant

https://www.guardantcomplete.com/products/guardant360-cdx/

Category:  Cancer Show Health

Market Whales and Their Recent Bets on Guardant Health Options

(9 days ago) WEBGuardant Health, Inc, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. an FDA-approved companion diagnostic for several targeted

https://www.benzinga.com/insights/options/24/05/38799103/market-whales-and-their-recent-bets-on-guardant-health-options

Category:  Cancer Show Health

FDA Advisory Panel Review of Guardant Health's Shield Blood Test …

(6 days ago) WEBPALO ALTO - Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical Genetics Panel of the U.S. Food and Drug Administration Medical Devices Advisory Committee is scheduled to review the premarket approval (PMA) application for the company's Shield blood test for …

https://www.marketscreener.com/quote/stock/GUARDANT-HEALTH-INC-46434671/news/FDA-Advisory-Panel-Review-of-Guardant-Health-s-Shield-Blood-Test-to-Screen-for-Colorectal-Cancer-to-46504540/

Category:  Food,  Medical Show Health

Guardant Health Receives ‘Buy’ Rating on Strong Q1 Performance …

(Just Now) WEBGuardant Health, Inc. is a precision oncology company, which engages in provision of precision oncology testing and development services. It focuses performing blood tests, vast data sets, and

https://markets.businessinsider.com/news/stocks/guardant-health-receives-buy-rating-on-strong-q1-performance-and-positive-financial-outlook-1033371016

Category:  Health Show Health

POSTPONED - Vaccines and Related Biological Products Advisory …

(7 days ago) WEBFOR FURTHER INFORMATION CONTACT: Sussan Paydar or Prabhakara Atreya, Center for Biologics Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 71, Silver Spring

https://www.fda.gov/advisory-committees/advisory-committee-calendar/postponed-vaccines-and-related-biological-products-advisory-committee-may-16-2024-meeting

Category:  Food Show Health

Second House panel advances two-year telehealth extension

(9 days ago) WEBSusan Walsh/AP. W ASHINGTON — A House subcommittee on Thursday advanced legislation that would extend some pandemic-era telehealth policies in Medicare for two years, bringing the panel’s

https://www.statnews.com/2024/05/16/telehealth-extension-house-panel/

Category:  Health Show Health

Draft Senate Finance Committee Bill Addressing Drug Shortages …

(4 days ago) WEBCCF is a health policy and research center dedicated to expanding and improving health coverage for America's children and families Draft Senate Finance Committee Bill Addressing Drug Shortages Includes Broad Rollback of Medicaid Inflation-Related Rebates for Generic Drugs, Raises Serious Concerns. May 14, 2024 Edwin Park.

https://ccf.georgetown.edu/2024/05/14/draft-senate-finance-committee-bill-addressing-drug-shortages-includes-broad-rollback-of-medicaid-inflation-related-rebates-for-generic-drugs-raises-serious-concerns/

Category:  Health Show Health

Guardant Health Announces Inducement Grants Under Nasdaq …

(9 days ago) WEBPALO ALTO, Calif., May 17, 2024--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on April 22, 2024, the Compensation Committee of Guardant’s Board

https://finance.yahoo.com/news/guardant-health-announces-inducement-grants-120500554.html

Category:  Health Show Health

Health tech solutions offered to combat Black maternal mortality

(3 days ago) WEBTaitt noted she was the 88th Black woman in the U.S. in 2020 to raise over $1 million for her company. “That’s abysmal,” she said. Hanna recently received $9 million in funding from big

https://www.statnews.com/2024/05/17/health-tech-solutions-black-maternal-mortality/

Category:  Health Show Health

2024-04-22 NDAQ:GH Press Release Guardant Health Inc

(1 days ago) WEBGuardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the Molecular and Clinical Genetics Panel of the U.S. Food and Drug Administration Medical Devices Advisory Committee is scheduled to review the premarket approval (PMA) application for the company’s Shield™ …

https://stockhouse.com/news/press-releases/2024/04/22/fda-advisory-panel-review-of-guardant-health-s-shield-tm-blood-test-to-screen

Category:  Food,  Medical Show Health

FDA panel to consider MDMA for PTSD treatment - NBC News

(3 days ago) WEBThe FDA's panel of independent advisers will on June 4 deliberate whether to recommend approval for the first MDMA-assisted therapy for PTSD, Lykos Therapeutics said.

https://www.nbcnews.com/health/mental-health/fda-panel-consider-psychedelic-party-drug-mdma-molly-ptsd-rcna151041

Category:  Health Show Health

Guardant Health, Inc. - Guardant Health receives FDA approval for

(9 days ago) WEBPALO ALTO, Calif.--(BUSINESS WIRE)-- Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, announced today that the U.S. Food and Drug Administration (FDA) has approved its Guardant360 ® CDx liquid biopsy test as a companion diagnostic to identify advanced or metastatic breast cancer patients with …

https://investors.guardanthealth.com/press-releases/press-releases/2023/Guardant-Health-receives-FDA-approval-for-Guardant360-CDx-as-companion-diagnostic-for-Menarini-Groups-ORSERDU-for-treatment-of-patients-with-ESR1-mutations-in-ER-HER2--advanced-or-metastatic-breast-cancer/default.aspx

Category:  Food,  Cancer Show Health

Over 115 million pills containing illicit fentanyl seized by law

(4 days ago) WEBLaw enforcement seizures of illicit fentanyl increased dramatically in number and size between 2017 to 2023 in the U.S., especially in pill form, according to a new study funded by the National Institutes of Health’s (NIH) National Institute on Drug Abuse (NIDA). The number of individual pills containing fentanyl seized by law enforcement was 2,300 …

https://www.nih.gov/news-events/news-releases/over-115-million-pills-containing-illicit-fentanyl-seized-law-enforcement-2023

Category:  Health Show Health

Filter Type: